These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Putranjivain A from Euphorbia jolkini inhibits both virus entry and late stage replication of herpes simplex virus type 2 in vitro. Cheng HY; Lin TC; Yang CM; Wang KC; Lin LT; Lin CC J Antimicrob Chemother; 2004 Apr; 53(4):577-83. PubMed ID: 14998984 [TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus. Albiol Matanic VC; Castilla V Int J Antimicrob Agents; 2004 Apr; 23(4):382-9. PubMed ID: 15081088 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of virus-encoded thymidine kinase suppresses herpes simplex virus replication in vitro and in vivo. Watkins AM; Dunford PJ; Moffatt AM; Wong-Kai-In P; Holland MJ; Pole DS; Thomas GM; Martin J; Roberts NA; Mulqueen MJ Antivir Chem Chemother; 1998 Jan; 9(1):9-18. PubMed ID: 9875372 [TBL] [Abstract][Full Text] [Related]
11. Evaluating the toxicity of selected types of nanochemicals. Kumar V; Kumari A; Guleria P; Yadav SK Rev Environ Contam Toxicol; 2012; 215():39-121. PubMed ID: 22057930 [TBL] [Abstract][Full Text] [Related]
12. Rose bengal inhibits herpes simplex virus replication in vero and human corneal epithelial cells in vitro. Chodosh J; Banks MC; Stroop WG Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2520-7. PubMed ID: 1321799 [TBL] [Abstract][Full Text] [Related]
13. In vitro toxicity of silver nanoparticles on murine peritoneal macrophages. Shavandi Z; Ghazanfari T; Moghaddam KN Immunopharmacol Immunotoxicol; 2011 Mar; 33(1):135-40. PubMed ID: 20507217 [TBL] [Abstract][Full Text] [Related]
14. Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR. Thi TN; Deback C; Malet I; Bonnafous P; Ait-Arkoub Z; Agut H Antiviral Res; 2006 Mar; 69(3):152-7. PubMed ID: 16388859 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of glycoporphyrin derivatives and their antiviral activity against herpes simplex virus types 1 and 2. Tomé JP; Neves MG; Tomé AC; Cavaleiro JA; Mendonça AF; Pegado IN; Duarte R; Valdeira ML Bioorg Med Chem; 2005 Jun; 13(12):3878-88. PubMed ID: 15911304 [TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro study on the anti-herpetic effect of phytochemically characterized aqueous and ethanolic extracts of Salvia officinalis grown at two different locations. Schnitzler P; Nolkemper S; Stintzing FC; Reichling J Phytomedicine; 2008 Jan; 15(1-2):62-70. PubMed ID: 18068963 [TBL] [Abstract][Full Text] [Related]
17. Silver nanoparticles: evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cells. Hackenberg S; Scherzed A; Kessler M; Hummel S; Technau A; Froelich K; Ginzkey C; Koehler C; Hagen R; Kleinsasser N Toxicol Lett; 2011 Feb; 201(1):27-33. PubMed ID: 21145381 [TBL] [Abstract][Full Text] [Related]
19. Possible mode of action of antiherpetic activities of a proteoglycan isolated from the mycelia of Ganoderma lucidum in vitro. Liu J; Yang F; Ye LB; Yang XJ; Timani KA; Zheng Y; Wang YH J Ethnopharmacol; 2004 Dec; 95(2-3):265-72. PubMed ID: 15507347 [TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]